1. Home
  2. NKTR vs AMBI Comparison

NKTR vs AMBI Comparison

Compare NKTR & AMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • AMBI
  • Stock Information
  • Founded
  • NKTR 1990
  • AMBI 1995
  • Country
  • NKTR United States
  • AMBI Brazil
  • Employees
  • NKTR N/A
  • AMBI N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • AMBI Environmental Services
  • Sector
  • NKTR Health Care
  • AMBI Industrials
  • Exchange
  • NKTR Nasdaq
  • AMBI Nasdaq
  • Market Cap
  • NKTR 247.9M
  • AMBI 290.4M
  • IPO Year
  • NKTR 1994
  • AMBI N/A
  • Fundamental
  • Price
  • NKTR $0.90
  • AMBI $4.95
  • Analyst Decision
  • NKTR Strong Buy
  • AMBI
  • Analyst Count
  • NKTR 5
  • AMBI 0
  • Target Price
  • NKTR $4.50
  • AMBI N/A
  • AVG Volume (30 Days)
  • NKTR 1.5M
  • AMBI 11.3K
  • Earning Date
  • NKTR 03-03-2025
  • AMBI 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • AMBI N/A
  • EPS Growth
  • NKTR N/A
  • AMBI 3161.09
  • EPS
  • NKTR N/A
  • AMBI 0.56
  • Revenue
  • NKTR $93,137,000.00
  • AMBI $504,573,816.00
  • Revenue This Year
  • NKTR $12.85
  • AMBI N/A
  • Revenue Next Year
  • NKTR N/A
  • AMBI N/A
  • P/E Ratio
  • NKTR N/A
  • AMBI $8.62
  • Revenue Growth
  • NKTR 5.53
  • AMBI 25.13
  • 52 Week Low
  • NKTR $0.50
  • AMBI $3.07
  • 52 Week High
  • NKTR $1.93
  • AMBI $8.20
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 40.16
  • AMBI 47.98
  • Support Level
  • NKTR $0.87
  • AMBI $4.25
  • Resistance Level
  • NKTR $0.94
  • AMBI $4.98
  • Average True Range (ATR)
  • NKTR 0.09
  • AMBI 0.55
  • MACD
  • NKTR -0.01
  • AMBI 0.01
  • Stochastic Oscillator
  • NKTR 15.63
  • AMBI 35.50

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About AMBI Ambipar Emergency Response

Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.

Share on Social Networks: